Vitrolife AB (publ) (VTRLY)
OTCMKTS · Delayed Price · Currency is USD
9.50
-5.80 (-37.91%)
Feb 11, 2026, 12:02 PM EST
Vitrolife AB Market Cap
Vitrolife AB has a market cap or net worth of $1.3 billion as of February 12, 2026. Its market cap has decreased by -51.77% in one year.
Market Cap
1.30B
Enterprise Value
1.39B
Revenue
373.21M
Ranking
n/a
PE Ratio
n/a
Stock Price
$9.50
Market Cap Chart
Since June 27, 2001, Vitrolife AB's market cap has increased from 47.59M to 1.30B, an increase of 2,641.72%. That is a compound annual growth rate of 14.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 1.30B | -35.37% |
| Dec 30, 2025 | 2.02B | -23.41% |
| Dec 30, 2024 | 2.64B | 0.83% |
| Dec 29, 2023 | 2.61B | 8.07% |
| Dec 30, 2022 | 2.42B | -71.15% |
| Dec 30, 2021 | 8.38B | 193.22% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| OpGen | 337.95M |
| Tian'an Technology Group | 145.66M |
| Zomedica | 124.94M |
| RetinalGenix Technologies | 59.54M |
| CS Diagnostics | 59.50M |
| Positron | 58.27M |
| Vivos | 31.43M |
| Guided Therapeutics | 28.51M |